Zentalis Pharmaceuticals, Inc. (ZNTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 11.31 |
| Open | 11.88 |
| Bid | 11.04 x 100 |
| Ask | 11.13 x 600 |
| Day's range | 10.95 - 12.00 |
| 52-week range | 9.56 - 31.46 |
| Volume | |
| Avg. volume | 827,759 |
| Market cap | 788.957M |
| Beta (5Y monthly) | 1.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price
Key Insights The projected fair value for Zentalis Pharmaceuticals is US$30.67 based on 2 Stage Free Cash Flow to...
- Zacks
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet
The consensus price target hints at a 136.4% upside potential for Zentalis Pharmaceuticals, Inc. (ZNTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- GuruFocus.com
Zentalis Pharmaceuticals Inc (ZNTL) Reports Full Year 2023 Financial Results and Provides ...
Robust Clinical Pipeline and Strong Cash Position Highlighted in Latest Earnings Report
© 2024 Yahoo. All rights reserved.